+ All Categories
Home > Documents > Mercy Medical Center...BPH and Overactive Bladder • Discuss the work-up and algorithm for...

Mercy Medical Center...BPH and Overactive Bladder • Discuss the work-up and algorithm for...

Date post: 07-Aug-2020
Category:
Upload: others
View: 1 times
Download: 0 times
Share this document with a friend
9
Transcript
Page 1: Mercy Medical Center...BPH and Overactive Bladder • Discuss the work-up and algorithm for treatment of benign prostatic hyperplasia. • Review the recommendations for treatment
Page 2: Mercy Medical Center...BPH and Overactive Bladder • Discuss the work-up and algorithm for treatment of benign prostatic hyperplasia. • Review the recommendations for treatment
Page 3: Mercy Medical Center...BPH and Overactive Bladder • Discuss the work-up and algorithm for treatment of benign prostatic hyperplasia. • Review the recommendations for treatment
Page 4: Mercy Medical Center...BPH and Overactive Bladder • Discuss the work-up and algorithm for treatment of benign prostatic hyperplasia. • Review the recommendations for treatment

A day of professional and clinical

development

MercyCareProvider Retreat

ACCREDITATION This activity has been planned and implemented in accordance with the

Essential Areas and Policies of the Iowa Medical Society (IMS) through thejoint sponsorship of The Cedar Rapids Medical Education Foundation and MercyCare Community Physicians. The Cedar Rapids Medical EducationFoundation is accredited by the IMS to provide continuing medical educationfor physicians.

The Cedar Rapids Medical Education Foundation designates this educational activity for a maximum of 3.75 AMA PRA Category 1 Credit™. Physicians shouldonly claim credit commensurate with their participationin the activity.

All speakers have disclosed that they do not have any relevant financial interestwith any entity producing, marketing, re-selling, or distributing health care goodsor services consumed by or used on patients, this does not include providersof clinical services directly to patients.

CONFLICT OF INTEREST DISCLOSUREAs a sponsor accredited by the Iowa Medical Society, the Cedar Rapids MedicalEducation Program must assure balance, independence, objectivity and scien-tific rigor in all its individually sponsored or jointly sponsored educational activ-ities. All faculty participating in a sponsored activity are expected to disclose tothe activity audience any significant financial interest or other relationship (1)with the manufacturer(s) of any commercial product(s) and/or provider(s) ofcommercial services discussed in an educational presentation and (2) with anycommercial supporters of the activity (significant financial interest or other relationship can include such things as grants, or research support, employee,consultant, major stock holder, member of speakers bureau, etc.) The intent ofthis disclosure is not to prevent a speaker with a significant financial or otherrelationship from making a presentation, but rather to provide listeners with information on which they can make their own judgments. It remains for the audience to determine whether the speaker’s interests or relationship may in-fluence the presentation with regard to exposition or conclusion. Disclosureforms for each presenter are on file in the CME office. DURING PRESENTA-TIONS THERE ARE OCCASIONALLY DISCUSSIONS OF UNAPPROVEDUSE OF FDA APPROVED DRUGS, DEVICES OR TREATMENTS. THIS MUSTBE DISCLOSED TO THE AUDIENCE DURING THE LECTURE.

MercyCare Provider Retreat

The Hotel Kirkwood 7725 Kirkwood Blvd. SWCedar Rapids, IA 52404

Saturday, February 4The Hotel Kirkwood

Jointly Provided By:

Cedar RapidsMedical Education Foundation

Page 5: Mercy Medical Center...BPH and Overactive Bladder • Discuss the work-up and algorithm for treatment of benign prostatic hyperplasia. • Review the recommendations for treatment

8:00 – 8:15 am Welcome and Introduction

8:15 – 9:00 am

Andrew Peterson, MDSport-Related Concussion

• Review the recognition andevaluation of a sport-relatedconcussion including basicmanagement and return toplay decisions.

9:00 – 9:45 am

Kelly Hoenig, MD

The Death of Sulfonylureas:A Review of New DiabetesMedications

• Review GLP-1 Agonists, DPP-IV Inhibitors and SGLT-2Inhibitors.

• Analyze new evidence supporting the use of liraglutide and empagliflozin.

• Compare and contrast treatment algorithms from the American Diabetes Association and the American Associationof Clinical Endocrinologists.

9:45 – 10:00 am Break

10:00 – 10:45 am

Matt Smith, MD

Urology Update: BPH and Overactive Bladder

• Discuss the work-up and algorithm for treatment of benign prostatic hyperplasia.

• Review the recommendations for treatment of hematuria andPSA in the primary care setting.

• Review female voiding dysfunction includingurgency and urge incontinence, focusing onthe initial work-up and when to refer to aurologist.

10:45 – 11:30 am

Aaron Benson, MD

Primary Care Update on Cochlear and Hybrid Implantation

• Learn about cochlear and hybrid implants.

• Discuss when it is appropriate to refer for either of these implants.

No Registration FeesRSVP to Sue Schlarmann

by January 25 at (319) 361-8736or [email protected]

MercyCare Provider Retreat

SCHEDULE11:30 am – 12:15 pm

Anwar Ahmed, MD

Hyponatremia: “What every physicianneeds to know.”

• Discuss the physiology of water balance and hyponatremia.

• Discuss the diagnosis and clinical implications of hyponatremia.

• Review treatment of hyponatremia.

12:15 p.m. Lunch

Page 6: Mercy Medical Center...BPH and Overactive Bladder • Discuss the work-up and algorithm for treatment of benign prostatic hyperplasia. • Review the recommendations for treatment
Page 7: Mercy Medical Center...BPH and Overactive Bladder • Discuss the work-up and algorithm for treatment of benign prostatic hyperplasia. • Review the recommendations for treatment
Page 8: Mercy Medical Center...BPH and Overactive Bladder • Discuss the work-up and algorithm for treatment of benign prostatic hyperplasia. • Review the recommendations for treatment
Page 9: Mercy Medical Center...BPH and Overactive Bladder • Discuss the work-up and algorithm for treatment of benign prostatic hyperplasia. • Review the recommendations for treatment

Recommended